The Intracellular Domain of Amyloid Precursor Protein is a Potential Therapeutic Target in Alzheimer’s Disease

E-ISSN： 1875-6220|11|4|243-258

ISSN： 1570-1638

Source： Current Drug Discovery Technologies, Vol.11, Iss.4, 2014-01, pp. : 243-258

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alzheimer’s disease: towards therapeutic manipulation of the amyloid precursor protein and amyloid &bgr;-peptides

By Larner A.J. Rossor M.N.

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 10, 1997-10 ,pp. : 1115-1127

Informa Healthcare

Access to resources Recommend Favorite

The Amyloid &bgr;-Protein Precursor and Alzheimer's Disease. Therapeutic Approaches

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 5, Iss. 4, 2005-12 ,pp. : 271-283

Bentham Science Publishers

Access to resources Recommend Favorite

Tau protein as a therapeutic target in Alzheimer’s disease and other neurodegenerative disorders

By Larner A.J.

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 10, 1999-10 ,pp. : 1359-1370

Informa Healthcare

Access to resources Recommend Favorite

Amyloid &bgr; -Protein Assembly as a Therapeutic Target of Alzheimer's Disease

Current Pharmaceutical Design, Vol. 14, Iss. 30, 2008-10 ,pp. : 3231-3246

Bentham Science Publishers

Access to resources Recommend Favorite

Astroglial Connexins as a Therapeutic Target for Alzheimer's Disease

Current Pharmaceutical Design, Vol. 23, Iss. 33, 2018-01 ,pp. : 4958-4968

Bentham Science Publishers

Access to resources Recommend Favorite